A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery
Conditions: Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery Interventions: Drug: SHR-2004; Drug: Enoxaparin Sodium Injection; Rivaroxaban Tablets Sponsors: Beijing Suncadia Pharmaceuticals Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials
A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer
Conditions: Ovarian Cancer; Cervix Cancer; Metastatic Cancer; Advanced Cancer; Gynecologic Cancer Interventions: Biological: CD70 CAR-T cells; Biological: CD70 CAR-T cells Sponsors: Chongqing Precision Biotech Co., Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
Evaluation of Amino Acid Metabolism Changes in Ovarian Cancer
Conditions: Ovarian Cancer Interventions: Other: dynamic test for amino acid metabolism Sponsors: University Hospital, Grenoble Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
Intraperitoneal LSTA1 in CRS-HIPEC
Conditions: Colorectal Cancer; Ovarian Carcinoma; Appendix Cancer; Peritoneal Metastases Interventions: Drug: CRS-HIPEC + LSTA1; Procedure: CRS-HIPEC alone Sponsors: University of California, San Diego Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
A Study of SHR-A1921 With or Without Carboplatin in Subjects With Ovarian Cancer
Conditions: Ovarian Cancer Interventions: Drug: SHR-1921; Drug: carboplatin; Drug: carboplatin; Drug: platinum-based doublet chemotherapy Sponsors: Suzhou Suncadia Biopharmaceuticals Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2024 Category: Research Source Type: clinical trials
The prevention of rectovaginal fistula after rectal cancer surgery by packing with laparoscopic dislocated fat flap containing ovarian vascular pedicle anterior to the anastomotic stoma: a parallel group randomized controlled trial protocol
In this study, we introduce a new method to prevent RVF during rectal cancer radical operation.MethodsIn this randomized controlled trial (RCT), all operations are performed according to the principle of total mesorectal excision (TME) radical resection in rectal cancer surgery. All eligible participants will be divided into two groups: the experimental group and the control group. Experimental group: the anterior rectal wall of about 1 cm distal to the anastomosis was dislocated. Before the anastomosis of the rectal end, a fat flap (usually left side) containing the ovarian vascular pedicle was dislocated, measured by 1...
Source: Trials - January 18, 2024 Category: Research Source Type: clinical trials
NYSCF Scientific Discovery Biobank
Conditions: ALS; Amyotrophic Lateral Sclerosis; Alzheimer Disease; Alzheimer Disease, Early Onset; Alzheimer Disease, Late Onset; Batten Disease; Corticobasal Degeneration; Dementia; Frontotemporal Dementia; Huntington Disease; Lewy Body Disease; Multiple Sclerosis; Multiple System Atrophy; Parkinson Disease; Parkinson ' s Disease and Parkinsonism; Progressive Supranuclear Palsy; INAD; Diabetes; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetes Mellitus, Type 1; Macular Degeneration; Ovarian Cancer; Cervical Cancer; Uterine Cancer; Vaginal Cancer; Vulvar Cancer; PTSD; Post Traumatic Stress Disorder Interventions: Othe...
Source: ClinicalTrials.gov - January 12, 2024 Category: Research Source Type: clinical trials
Machine Learning Predicts Survival and Mutations in Ovarian Metastases of Colorectal Cancer
Conditions: Ovarian Metastases of Colorectal Cancer Interventions: Other: Prediction model Sponsors: Sixth Affiliated Hospital, Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials
A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors
Conditions: ER+ HER2- Advanced Breast Cancer; High-grade Serous Ovarian Cancer (HGSOC) Interventions: Drug: AZD8421; Drug: Camizestrant; Drug: Ribociclib; Drug: Palbociclib; Drug: Abemaciclib Sponsors: AstraZeneca Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 3, 2024 Category: Research Source Type: clinical trials
Maintenance Therapy After Platinum-containing Chemotherapy in Patients With Recurrent Ovarian Cancer
Conditions: Ovarian Cancer Interventions: Drug: Fluzoparib Capsules; Drug: Apatinib Mesylate Tablets Sponsors: The First Affiliated Hospital of Xiamen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 3, 2024 Category: Research Source Type: clinical trials
Choices About Genetic Testing And Learning Your Risk With Smart Technology
Conditions: Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer; Breast Cancer; Pancreas Cancer; Colorectal Cancer; Endometrial Cancer; Prostate Cancer Interventions: Device: Relational Agent; Other: Clinical Letter Sponsors: Rutgers, The State University of New Jersey Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 28, 2023 Category: Research Source Type: clinical trials
Prognostic Value of MRD Detection in CA125 Non-sensitive Ovarian Cancer Patients
Conditions: Ovarian Cancer Sponsors: West China Second University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 27, 2023 Category: Research Source Type: clinical trials
Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression
Conditions: Ovarian Cancer; Oligometastatic Disease; Serous Ovarian Tumor Interventions: Drug: Niraparib oral tablets Sponsors: MedSIR Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 22, 2023 Category: Research Source Type: clinical trials
RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer
Conditions: Primary Peritoneal Cancer; Fallopian Tube; Epithelial Ovarian Interventions: Drug: RC88 Sponsors: RemeGen Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2023 Category: Research Source Type: clinical trials
PRO1107 in Patients With Advanced Solid Tumors
Conditions: Endometrial Cancer; Ovarian Cancer; Triple Negative Breast Cancer; GastroEsophageal Cancer; Non-small Cell Lung Cancer; Urothelial Carcinoma Interventions: Drug: PRO1107 Sponsors: ProfoundBio US Co. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2023 Category: Research Source Type: clinical trials
